Shenzhen HwaGen
Pharmaceutical Co., Ltd. (HwaGen Pharmaceutical)
was founded in December of 2015, led by a “National 1000 Talents Plan” awardee.
The company has a highly-skilled, international and professional team
specialized in R&D and manufacturing, and owns a R&D center and a pilot
plant both of which covering 2,000 m2, plus a new GMP certified
commercial production facility covering an area of 20, 000 m2. By
leveraging its core competency in chiral synthesis, enzymatic catalysis and
continuous flow micro reaction, HwaGen Pharmaceutical is dedicated to
delivering niche Intermediates & APIs and CDMO services for global
pharmaceutical industry.